Position in AMGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$41,864,872
+$3,148,355 QoQ
Shares Held
118,985
+0.6% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
2.73%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026SMITH CHAS P & ASSOCIATES PA CPAS holds $179,997,284 across 8 Drug Manufacturers - General names. AMGN ranks #3 (23.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
251,939 | $61,583,969 | |
| 2 | MRK |
Merck & Co., Inc.
|
367,523 | $44,209,341 | |
| 3 | AMGN |
Amgen Inc
This page
|
118,985 | $41,864,872 | |
| 4 | NVO |
Novo Nordisk A S
|
801,586 | $29,458,285 | |
| 5 | LLY |
ELI LILLY & Co
|
1,254 | $1,153,391 | |
| 6 | ABBV |
AbbVie Inc.
|
4,249 | $924,115 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
7,023 | $425,944 | |
| 8 | PFE |
Pfizer Inc
|
13,439 | $377,367 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $41,864,872 | 118,985 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $38,716,517 | 118,287 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $19,549,122 | 69,274 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $32,591,904 | 116,729 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $35,626,054 | 114,351 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $29,073,870 | 111,548 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $35,727,289 | 110,882 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $35,519,316 | 113,680 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $31,842,134 | 111,994 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $31,347,520 | 108,838 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $28,479,153 | 105,965 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $21,637,625 | 97,458 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $302,429 | 1,251 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $341,957 | 1,302 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $423,977 | 1,881 | Shares | Sole | 2022-11-22 | |
| 2022-06-30 | $421,152 | 1,731 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $407,950 | 1,687 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $249,041 | 1,107 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $357,464 | 1,681 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $408,768 | 1,677 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $417,254 | 1,677 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $385,575 | 1,677 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $423,430 | 1,666 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $392,942 | 1,666 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $318,488 | 1,571 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||